SK Innovation Earnings Rebound Yet Losses Persist: Key Risks SK Innovation shows recovering operating profit on improving refining margins, but net loss persists due to one off JV exit items; consensus is HOLD with limited upside. 2026년 05월 01일 English
Hyundai Steel Profit Stabilizes as Revenue Contracts – What It Means Hyundai Steel has contracting revenue but sharp margin improvement; analysts rate Buy with targets implying about 11% upside, though net losses and execution risk remain. 2026년 05월 01일 English
Naver Earnings Power Up: Stock Pricing AI Monetization Naver is rated Buy as revenue grows 10.7% and operating profit 12.7% YoY, but net income drops 43.5% due to FX, suggesting operating strength outweighs earnings noise. 2026년 04월 30일 English
Korea Aerospace Industries Earnings Jump – Strong upside potential Korea Aerospace Industries posts strong earnings growth, with net profit up 412% YoY and Buy consensus, offering favorable upside though margins and KF-21 schedule risks remain. 2026년 04월 30일 English
Kakao Stock Jumps on Earnings Rebound: What Next Kakao is rated Buy as earnings sharply rebounded, with revenue up 8.4% and operating profit up 211.8% YoY, while the stock still trades below the average analyst target. 2026년 04월 29일 English
LG Corporation Stock Holds Steady as Profits Deteriorate LG Corp stock is a Hold as margins stay deeply stressed: revenue -14.6% YoY, gross profit -2,789억, operating loss -4,213억. Net loss slightly improved, but earnings quality is the key risk. 2026년 04월 29일 English
Transocean Stock Holds Steady Despite Operating Gains: Key Risks Transocean shows improving operating profits and revenue growth, but EPS remains negative and ROE is deeply negative. Analyst consensus is Hold with a mean target below the current $6.52 price. 2026년 04월 28일 English
Celltrion Stock Momentum Shifts: Margin And Earnings Surge Celltrion is rated Buy as margins expand rapidly, operating profit accelerates, and three ADCs have moved to patient dosing with US fast track, supporting upside. 2026년 04월 28일 English
Organon Stock Jumps on Sun Pharma Deal: Key Risks Ahead Organon stock is rated Hold as Sun Pharma confirmed an all-cash $14 offer. Shares surged, but weakening earnings make it a deal-and-timing risk, not fundamentals, and upside is limited near today’s price. 2026년 04월 28일 English
Hana Financial Group Earnings Momentum Holds – Value Insight Hana Financial Group shows strong earnings momentum with double digit YoY growth, trades at low forward P/E 7.4, and holds a Wall Street buy consensus, but investors must watch regulatory and credit-cycle risks. 2026년 04월 28일 English
